Interventional technology firm Medtronic has submitted the final module of a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its Talent Thoracic stent-graft system.
Talent Thoracic provides a treatment option to open surgery for patients with aneurysm in the upper portion of the aorta, according to the Minneapolis-based firm.
By AuntMinnie.com staff writers
March 5, 2007
Related Reading
BrainLab wins patent victory, February 8, 2007
Medtronic gets Japanese OK for Micro-Driver stent, September 20, 2006
Medtronic completes Endeavor enrollments, June 28, 2006
Medtronic to bring Endeavor to China, June 21, 2006
Medtronic nets French reimbursement approval, June 12, 2006
Copyright © 2007 AuntMinnie.com